Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Common Shares | Options Exercise | $823K | +5.16K | +77.01% | $159.40 | 11.9K | Apr 18, 2023 | Direct | F1 |
holding | PSA | Common Shares | 2K | Apr 18, 2023 | By Trust | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Apr 18, 2023 | Common Shares | 5.16K | $159.40 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Includes 1,704 deferred stock units. |
F2 | By Ronald P. Spogli as trustee. |
F3 | Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. |
F4 | This option was previously reported as an option for 5,000 common shares at an exercise price of $164.62, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. |